Te­va CEO Richard Fran­cis out­lines roadmap to 'get back to growth,' in­clud­ing some gener­ics port­fo­lio cuts

Te­va’s “next chap­ter” will in­volve some cuts to its gener­ics port­fo­lio, CEO Richard Fran­cis an­nounced on Thurs­day.

Best known as a ma­jor gener­ics mak­er, Te­va has been lean­ing more on R&D as part of Fran­cis’ new strat­e­gy to “piv­ot to growth.” That will in­volve trim­ming some low-mar­gin gener­ic prod­ucts that are al­ready be­ing sup­plied by mul­ti­ple oth­er man­u­fac­tur­ers, he re­vealed dur­ing a press call Thurs­day. While Fran­cis didn’t name any spe­cif­ic prod­ucts, he said the process will be a “mul­ti-year jour­ney.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER